Stay updated on T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial

Sign up to get notified when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the history, replacing the previous v3.4.2 entry in the record history.
    Difference
    0.1%
    Check dated 2026-03-12T01:05:12.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 banner on the page. Removed notices about government funding/operating status and the previous v3.4.1 revision.
    Difference
    0.7%
    Check dated 2026-02-11T12:12:04.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Added a site-wide funding/operating status notice. Updated the history version from v3.4.0 to v3.4.1.
    Difference
    0.7%
    Check dated 2026-02-04T06:49:26.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The new version adds a glossary display toggle, color-coded change highlights (green for additions, red for deletions) in the study history, and updates the revision label from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-01-28T04:31:20.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    A new revision entry v3.3.4 was added to the record history, while v3.3.3 was removed. This update does not alter study data or visible page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:24:08.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.3, and the HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer.
    Difference
    0.2%
    Check dated 2025-12-23T20:39:41.000Z thumbnail image

Stay in the know with updates to T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.